Completed OBSERVATIONAL NCT05288231

Cardiac Manifestation in Adolescent After Pfizer COVID-19 Injection in Thailand

Sponsor: Mahidol University

Updated 6 times since 2022 Last updated: May 29, 2022 Started: Nov 3, 2021 Primary completion: Nov 29, 2021 Completion: Mar 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05288231, this observational or N/A phase trial focuses on Covid-19 Vaccine and remains completed. Sponsored by Mahidol University, it has been updated 6 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jul 2022 — Jul 2024 [monthly]

Completed
May 2022 — Jul 2022 [monthly]

Completed

▶ Show 1 earlier version

Apr 2022 — May 2022 [monthly]

Completed

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mahidol University

Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand